Oral

[3O04m2] Neurodegenerative Disorders 1

Sat. Jul 2, 2022 10:00 AM - 11:00 AM Room 4 (Conference Building B5~7 (Okinawa Convention Center))

Chair: Kensuke Ikenaka

+Add all to schedule

[3O04m2-01] Phospholipid A triggers the formation of Parkinson's disease-like fibrils of alpha-synuclein

*Kensuke Ikenaka Ikenaka¹, Choong Chi-Jin¹, Cesar Aguirre¹, Keita Kakuda¹, Hideki Mochizuki¹ (1. Osaka University Graduate school of Medicine)

[3O04m2-02] Fatty acid-binding proteins 5/7 mediate the oligodendrocyte injury in a multiple sclerosis mouse model

*Kohji Fukunaga^1,2, Cheng An¹, Ichiro Kawahata¹ (1. Tohoku University Grad Sch Pharm Sci, Sendai, Japan, 2. BRI Pharma Inc.)

[3O04m2-03] Analysis of the mechanism of REM sleep focusing on behavior disorders associated with Parkinson's disease

*Ami Kaneko^1,2, Shinnosuke Yasugaki^1,3, Hideki Hayakawa⁴, Kensuke Ikenaka⁴, Cesar Aguirre⁴, Masashi Yanagisawa¹, Kousuke Baba^4,5, Hideki Mochizuki⁴, Yu Hayashi^1,6 (1. WPI-IIIS, Univ of Tsukuba, 2. Ph. D. Prog in Humanics, SIGMA, Univ of Tsukuba, 3. Doc Prog in Biomed Sci, Grad Sch of Comprehensive Human Sci, Univ of Tsukuba, 4. Dept of Neurology, Grad Sch of Medicine, Osaka Univ, 5. Dept of Neurology, Faculty of Medicine, Acad Res Division, Univ of Toyama, 6. Dept of Human Health Sci, Grad Sch of Medicine, Kyoto Univ)

[3O04m2-04] Impact of fatty acid-binding protein and dopamine receptor in α-synuclein propagation and development of disease-modifying drug for α-synucleinopathy

*Ichiro Kawahata¹, Kohji Fukunaga¹ (1. Grad Sch Pharm Sci, Tohoku Univ, Sendai, Japan)

Session information